Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Templin

Showing results (231-240 of 293) with videos related to

Pageof 30
Sort By:
International Journal of Cardiology|December 23, 2023
Influence of intracoronary hemodynamic forces on atherosclerotic plaque phenotypesAlessandro Candreva, Diego Gallo, Daniel Munhoz, et al.
The Journal of Clinical Investigation|June 25, 2011
Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery diseaseChristian Besler, Kathrin Heinrich, Lucia Rohrer, et al.
European Heart Journal. Cardiovascular Imaging|June 13, 2017
Effects of statins on plaque rupture assessed by optical coherence tomography in patients presenting with acute coronary syndromes: insights from the optical coherence tomography (OCT)-FORMIDABLE registrySebastiano Gili, Mario Iannaccone, Francesco Colombo, et al.
European Heart Journal|October 12, 2017
Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patientsFabrizio D'Ascenzo, Mario Iannaccone, Gaelle Saint-Hilary, et al.
Journal of the American College of Cardiology|September 1, 2022
Mammalian Target of Rapamycin Inhibition in Patients With ST-Segment Elevation Myocardial InfarctionBarbara E Stähli, Roland Klingenberg, Dik Heg, et al.
International Journal of Cardiology|January 1, 2019
New-generation drug-eluting stents for left main coronary artery disease according to the EXCEL trial enrollment criteria: Insights from the all-comers, international, multicenter DELTA-2 registryAkihito Tanaka, Gennaro Giustino, Ieva Briede, et al.
European Heart Journal|December 23, 2025
The junctional protein associated with coronary artery disease predicts adverse cardiovascular events in patients with acute coronary syndromes at high residual riskSimon Kraler, Luca Liberale, Amedeo Tirandi, et al.
Lancet (London, England)|January 31, 2026
Prediction of mortality, bleeding, and ischaemic events in patients with cancer and acute coronary syndrome: a model development and validation studyFlorian A Wenzl, Kok Weng Ow, Matthijs A Velders, et al.
ESC Heart Failure|November 20, 2024
Effects of sodium-glucose co-transporter inhibitors on individual clinical endpoints and quality of lifeJia Liao, Yang Chen, Zhiyu Ling, et al.
JACC. Cardiovascular Interventions|December 9, 2017
The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery DiseaseAlaide Chieffo, Akihito Tanaka, Gennaro Giustino, et al.
Pageof 30

Showing results (231-240 of 293) with videos related to

Sort By:
Pageof 30
International Journal of Cardiology|December 23, 2023
Influence of intracoronary hemodynamic forces on atherosclerotic plaque phenotypesAlessandro Candreva, Diego Gallo, Daniel Munhoz, et al.
The Journal of Clinical Investigation|June 25, 2011
Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery diseaseChristian Besler, Kathrin Heinrich, Lucia Rohrer, et al.
European Heart Journal. Cardiovascular Imaging|June 13, 2017
Effects of statins on plaque rupture assessed by optical coherence tomography in patients presenting with acute coronary syndromes: insights from the optical coherence tomography (OCT)-FORMIDABLE registrySebastiano Gili, Mario Iannaccone, Francesco Colombo, et al.
European Heart Journal|October 12, 2017
Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patientsFabrizio D'Ascenzo, Mario Iannaccone, Gaelle Saint-Hilary, et al.
Journal of the American College of Cardiology|September 1, 2022
Mammalian Target of Rapamycin Inhibition in Patients With ST-Segment Elevation Myocardial InfarctionBarbara E Stähli, Roland Klingenberg, Dik Heg, et al.
International Journal of Cardiology|January 1, 2019
New-generation drug-eluting stents for left main coronary artery disease according to the EXCEL trial enrollment criteria: Insights from the all-comers, international, multicenter DELTA-2 registryAkihito Tanaka, Gennaro Giustino, Ieva Briede, et al.
European Heart Journal|December 23, 2025
The junctional protein associated with coronary artery disease predicts adverse cardiovascular events in patients with acute coronary syndromes at high residual riskSimon Kraler, Luca Liberale, Amedeo Tirandi, et al.
Lancet (London, England)|January 31, 2026
Prediction of mortality, bleeding, and ischaemic events in patients with cancer and acute coronary syndrome: a model development and validation studyFlorian A Wenzl, Kok Weng Ow, Matthijs A Velders, et al.
ESC Heart Failure|November 20, 2024
Effects of sodium-glucose co-transporter inhibitors on individual clinical endpoints and quality of lifeJia Liao, Yang Chen, Zhiyu Ling, et al.
JACC. Cardiovascular Interventions|December 9, 2017
The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery DiseaseAlaide Chieffo, Akihito Tanaka, Gennaro Giustino, et al.
Pageof 30